Prelude Therapeutics to collaborate with BeiGene to evaluate PRT2527 + zanubrutinib in hematologic cancers

“Mismatched” transplants now safe for blood cancer patients, study shows

A treatment approach using the drug cyclophosphamide can prevent most graft-versus-host disease in blood cancer patients without a donor match, new UVA Cancer Center research reveals.

July 18, 2025

Vol.51 No.28

In Brief

John Leonard named director of Center for Blood Cancers, chief of Division of Hematology and Medical Oncology at NYU Langone

John P. Leonard, an expert in lymphoma and other blood cancers, was named director of the Center for Blood Cancers and chief of the Division of Hematology and Medical Oncology in NYU Grossman School of Medicine’s Department of Medicine. The Division of Hematology and Medical Oncology is a major clinical arm of the Perlmutter Cancer Center.

July 11, 2025

Vol.51 No.27

In Brief

David Ryan named president of Mass General Brigham Cancer Institute

David Ryan was named the inaugural president of the Mass General Brigham’s Cancer Institute following a national search process.

May 02, 2025

Vol.51 No.17

In Brief

Casirati, De Wolf, Persaud, Rehman awarded $260,000 research grants from DKMS

Gabriele Casirati, of Boston Children’s Hospital, Susan E. De Wolf, of Memorial Sloan Kettering Cancer Center, Stephen Persaud, of Washington University School of Medicine, and Abdur Rehman, of the University of Texas MD Anderson Cancer Center, were awarded DKMS’ research grant in honor of John A. Hansen.

April 11, 2025

Vol.51 No.14

In Brief

Don Dizon to join Tufts as system chief of hematology-oncology

Don S. Dizon will join Tufts Medicine in June 2025 as the system chief of hematology-oncology for the cancer service line. He will be proposed as the Jane F. Desforges endowed Professor in Hematology-Oncology at Tufts University School of Medicine.

April 04, 2025

Vol.51 No.13

In Brief

Kimberly Stegmaier appointed chair of pediatric oncology at Dana-Farber

Kimberly Stegmaier was named chair of Pediatric Oncology at Dana-Farber Cancer Institute and associate chief of the Division of Hematology/Oncology at Boston Children’s Hospital. Her appointment is effective April 1.

February 21, 2025

Vol.51 No.07

Prelude Therapeutics to collaborate with BeiGene to evaluate PRT2527 + zanubrutinib in hematologic cancers

YOU MAY BE INTERESTED IN

“Mismatched” transplants now safe for blood cancer patients, study shows

John Leonard named director of Center for Blood Cancers, chief of Division of Hematology and Medical Oncology at NYU Langone

David Ryan named president of Mass General Brigham Cancer Institute

Casirati, De Wolf, Persaud, Rehman awarded $260,000 research grants from DKMS

Don Dizon to join Tufts as system chief of hematology-oncology

Kimberly Stegmaier appointed chair of pediatric oncology at Dana-Farber

Renew today!

Subscriber content

Never miss an issue!

Login